Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-014704
Filing Date
2013-03-06
Accepted
2013-03-06 19:34:07
Documents
1
Period of Report
2013-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3837
  Complete submission text file 0001209191-13-014704.txt   5158
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
YOUNG JAMES F (Reporting) CIK: 0001219864 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 13671209